Theraclion SA

Theraclion SA

0.60
EUR
0.00
(0.00%)
45.39MMarket Cap
Apr 29Next Earn

Total Valuation

EUR

As of June 30, 2026, Theraclion SA carries a market capitalization of 45.39M, placing it among publicly traded companies globally. Its enterprise value stands at 50.34M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap45.39M
Enterprise Value50.34M

Important Dates

Theraclion SA's next confirmed earnings release is scheduled for April 29, 2027.

Earnings Date4/29/2027

Share Statistics

As of June 30, 2026, Theraclion SA has 73.10M shares outstanding.

Shares Outstanding73.10M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio-120.09
P/TBV Ratio-28.95

Financial Position

As of June 30, 2026, Theraclion SA maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

Current Ratio1.54
Debt / Equity-1,308.73

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count36.00

Stock Price Statistics

EUR

As of the close on November 17, 2026, Theraclion SA's stock has declined approximately 9.61% over the past 52 weeks. The 50-day moving average sits at 0.66, while the 200-day moving average is 0.62.

52-Week Price Change-9.61%
50-Day Moving Average0.66
200-Day Moving Average0.62

Balance Sheet

EUR

These figures are as of June 30, 2026. Total book value stands at -378,000.00, with working capital of 2.11M providing operational flexibility.

Total Debt4.95M
Equity (Book Value)-378,000.00
Book Value Per Share-0.01
Working Capital2.11M

Stock Splits

Theraclion SA's most recent stock split took place on July 26, 2016.

Last Split Date7/26/2016